Jiangsu, China

Pengfei Hu

This inventor holds 1 USPTO granted patent. Top assignee: Accuredit Therapeutics (Suzhou) Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pengfei Hu. Retrieved from https://idiyas.com/inventor/pengfei-hu-y885n8f7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Pengfei Hu in Base Editing

Introduction

Pengfei Hu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly in the area of base editing. His work focuses on developing novel tools that enhance the precision of genetic modifications.

Latest Patents

Pengfei Hu holds 1 patent related to his research. The patent is titled "Deaminases and variants thereof for use in base editing." This invention provides adenosine deaminases and their variants, nucleobase editors that incorporate these deaminases, compositions that include such editors, and methods for using these editors to generate modifications in target nucleobase sequences.

Career Highlights

Currently, Pengfei Hu is associated with Accuredit Therapeutics (Suzhou) Co., Ltd. His role in the company allows him to further his research and development efforts in the field of genetic editing. His innovative approach has positioned him as a key figure in advancing genetic technologies.

Collaborations

Pengfei Hu collaborates with notable colleagues, including Fuxin Shi and Jialin Tao. Their combined expertise contributes to the success of their projects and enhances the impact of their research in the scientific community.

Conclusion

Pengfei Hu's work in base editing represents a significant advancement in genetic engineering. His innovative patents and collaborations highlight his commitment to improving genetic modification techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…